Red Medtech
Medical device development, quality and regulatory consultancy for healthcare innovators, designers and manufacturers
Highlights
- New on EvolcAdded 2026-11-12
About Red Medtech
Red Medtech provides medical device project management, engineering, quality management system and regulatory compliance consulting. Its support covers product development from concept through production and post-market activities, including CE, UKCA and US regulatory documentation.
The company works with micro start-ups, SMEs and large international organizations, supporting innovators, designers and manufacturers of patient-care products. It was founded in 2021 by Professor Laurie Rowe and is based in Swansea, Wales.
Product: Consulting for medical device product development, project management, quality systems and regulatory compliance.
Jobs at Red Medtech
Leadership
- Laurie Rowe · Founder & DirectorSource: company website
More consulting & professional services companies
Red Peak Compliance
Safety compliance assessments and services for landlords, care providers and businesses in Essex and East LondonYoung companyNew on EvolcRed Pencil Consulting
Operational transformation and project execution consulting for automotive and industrial businessesNew on EvolcRed Qhse Services
QHSE consultancy for oil and gas operators: management systems, risk assessment, compliance and incident investigationYoung companyNew on EvolcRedburn Design
Product design and development services for businesses creating consumer and industrial productsNew on EvolcReddiowl
Technical coordination and business-to-business support for companies with UK and European operationsYoung companyNew on EvolcRedfearn Experts
Independent housing-condition surveys and expert witness reports for solicitors, councils and housing providers in EnglandNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
No confirmed website technologies in the latest recorded checks.
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.